Meridian Bioscience's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Meridian is a life science company that manufactures and distributes diagnostic test kits, rare reagents, specialty biol... Read more

Based on data from Meridian Bioscience's latest SEC filings

Annual Revenue

Based on data from Meridian Bioscience's latest SEC filings

Employees

John P. Kenny's photo - CEO of Meridian Bioscience

CEO

John P. Kenny

CEO Approval Rating

66/100

OVERVIEW

Founded:

1977

Headquarters:

CincinnatiOhio

Status:

PublicIndependent Company of NASDAQVIVO

Industry Sector:

- -

SIC Code:

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Trovagene a competitor of Meridian Bioscience?

Want more news like this in your inbox? Get access for free

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

Luminex is perceived as one of Meridian Bioscience's biggest rivals. Luminex was founded in 1995, and is headquartered in Austin, Texas. Luminex is in the Biotechnology industry. Luminex generates $115.8M more revenue vs. Meridian Bioscience.

Fluidigm is a top competitor of Meridian Bioscience. Fluidigm is a Public company that was founded in 1999 in South San Francisco, California. Fluidigm operates in the Biotechnology industry. Compared to Meridian Bioscience, Fluidigm has 115 fewer employees.

Cepheid is Meridian Bioscience's #3 rival. Cepheid is headquartered in Sunnyvale, California, and was founded in 1996. Cepheid competes in the Biotechnology industry. Cepheid generates 293% the revenue of Meridian Bioscience.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

John P. Kenny

CEO

- -
650
$0
$203.3M
1

Nachum Homi Shamir

President & CEO

72/100
914
$76.5M
$319M
2

Chris Linthwaite

President & CEO

80/100
589
$268.7M
$214.7M
3

John L. Bishop

Chairman & CEO

66/100
1,700
$32.6M
$596.3M
4

Kevin Gould

CEO

68/100
80
- -
5

Thomas H. Adams

Chairman & CEO

87/100
53
$45M
$ < 1M
6

William J. Caragol

Chairman & CEO

69/100
32
- -
$4.6M
7

Kevin Isett

Co-Founder & CEO

80/100
15
$18.9M
$6.2M
8

Michael Hunkapiller

Chairman & CEO

84/100
438
$438.5M
$78.7M
9

Gregory J. Galvin

Chairman & CEO

91/100
50
$72.7M
$2M
10

Hesaam Esfandyarpour

Founder & CEO

92/100
50
$77.5M
$6M

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$203.3M

Meridian Bioscience's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 143.1M. Over the last four quarters, Meridian Bioscience's revenue has decreased by 8.8%. Specifically, in Q2 2019's revenue was $48.4M; in Q1 2019, it was $50.2M; in Q4 2018, it was $51.5M; in Q3 2018, Meridian Bioscience's revenue was $53.1M.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
GenePOC, Inc.

Apr 2019

Source »
$50M
GenePOC is a medical device company that designs and manufactures molecular diagnostic instruments for healthcare organizations.
Magellan Diagnostics, Inc.

Mar 2016

Source »
$66M
Magellan Diagnostics develops and manufactures point-of-care systems, clinical laboratory instruments and analytical laboratory services.

-

-

Sep 2000

Source »
$9M
-

These are all the companies that Meridian Bioscience has acquired. Meridian Bioscience has acquired 3 companies and its latest acquisition was GenePOC, Inc. in Apr 2019. GenePOC is a medical device company that designs and manufactures molecular diagnostic instruments for healthcare organizations.

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Oasis Diagnostics is a non-invasive saliva based technology for rapid testing, sample collection and molecular diagnostics.
-
Nov 11, 2015
Equity
-

These are all the companies that Meridian Bioscience has invested in. Meridian Bioscience has invested 3 companies and its latest investment was GenePOC, Inc. in Apr 2019. GenePOC is a medical device company that designs and manufactures molecular diagnostic instruments for healthcare organizations.

Meridian Bioscience News

July 30, 20194-traders

Meridian Bioscience Reports Third Quarter 2019 Operating Results

(marketscreener.com) CINCINNATI, Ohio, July 30, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (N... See more »
June 4, 2019The Business Journals

One of Cincinnati's largest public company's closes on $50M acquisition

Meridian Bioscience of Greater Cincinnati has completed its previously announced $50 million acquisit... See more »
June 3, 2019ABF Journal

PNC Agents $125MM Revolver for Meridian Bioscience

Meridian Bioscience has entered into a $125 million revolving credit facility credit agreement with P... See more »
April 30, 2019BioPortfolio

Meridian Bioscience Reports Second Quarter 2019 Operating Results Suspends Quarterly Cash Dividend and Provides Fiscal 2019 Guidance for Pending Acquisition

Meridian Bioscience Inc. NASDAQ VIVO today announced financial results for the second quarter and fir... See more »
April 30, 2019RTTNews

Meridian Bioscience Cuts FY19 Outlook, Suspends Dividend - Quick Facts

While reporting financial results for the second quarter, Meridian Bioscience, Inc. (VIVO) on Tuesday... See more »

Meridian Bioscience Press Releases

November 17, 2017EconoTimes

VIVO) To Contact Brower Piven Before The Lead Plaintiff Deadline

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a clas... See more »
October 23, 2017econotimes

Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to Magellan Diagnostics

Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that the FDA has issued a Warning Letter rela... See more »
October 16, 2017streetinsider

Meridian Bioscience, Inc. Expects to Report Fiscal 2018 Revenue and Earnings Guidance on Thursday, October 19, 2017

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading diagnostic and life science component company, ex... See more »
October 16, 2017econotimes

Meridian Bioscience, Inc. Expects to Report Fiscal 2018 Revenue and Earnings Guidance on Thursday, October 19, 2017

Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and life science component company, exp... See more »
October 10, 2017streetinsider

Meridian Bioscience, Inc. Appoints Jack Kenny as Chief Executive Officer

Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has appointed John (Jack) P. Kenny a... See more »

Meridian Bioscience Videos

August 27, 2019Meridian Bioscience Youtube Channel

"Today's Trend In H pylori Testing and Treatment" on YOUTUBE

August 27, 2019Meridian Bioscience Youtube Channel

"Clostridium difficile It's Complicated!" on YOUTUBE

August 22, 2019Meridian Bioscience Youtube Channel

"Revogene Workflow" on YOUTUBE

August 22, 2019Meridian Bioscience Youtube Channel

"Revogene Set up" on YOUTUBE

July 14, 2019Meridian Bioscience Youtube Channel

"Revogene PIE" on YOUTUBE

June 28, 2019Meridian Bioscience Vimeo Channel

"5 PM on Friday ... A Skype Tale" on VIMEO

Cast: Meridian Bioscience... See more »
June 28, 2019Meridian Bioscience Vimeo Channel

"Video Workflow GenePOC CDiff" on VIMEO

Cast: Meridian Bioscience... See more »

Social Statistics

Headquarters

3471 River Hills Drive

Cincinnati, Ohio45244

513-271-3700

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Meridian is a life science company that manufactures and distributes diagnostic test kits, rare reagents, specialty biologicals and components. Meridian Bioscience was founded in 1977. Meridian Bioscience's headquarters is located in Cincinnati, Ohio,...

CEO

Meridian Bioscience's CEO, John P. Kenny, currently has an approval rating of 66%. Meridian Bioscience's primary competitors are Luminex, Fluidigm & Cepheid.

Website

meridianbioscience.com

Frequently Asked Questions about Meridian Bioscience

  1. When was Meridian Bioscience founded?

    Meridian Bioscience was founded in 1977
  2. Who is Meridian Bioscience's CEO?

    Meridian Bioscience's CEO is John P. Kenny
  3. How much revenue does Meridian Bioscience generate?

    Meridian Bioscience generates $203.3M in revenue
  4. How much funding does Meridian Bioscience have?

    Meridian Bioscience has historically raised $0 in funding
  1. Where is Meridian Bioscience's headquarters?

    Meridian Bioscience's headquarters is in Cincinnati Ohio, USA
  2. How many employees does Meridian Bioscience have?

    Meridian Bioscience has 650 employees
  3. Who are Meridian Bioscience's competitors?

    Meridian Bioscience's top competitors are Luminex, Fluidigm, Cepheid
  4. Who has Meridian Bioscience invested in?

    Meridian Bioscience's has invested in companies such as Oasis Diagnostics